Showing results (1271-1280 of 1,557) with videos related to
Sort By:
Pageof 156
Cell Chemical Biology|January 1, 2019
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AMLMatthias Brand, Baishan Jiang, Sophie Bauer, et al.Angewandte Chemie (International Ed. in English)|March 10, 2023
Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and DegraderMingxing Teng, Jie Jiang, Eric S Wang, et al.Science (New York, N.Y.)|October 3, 2024
Relocalizing transcriptional kinases to activate apoptosisRoman C Sarott, Sai Gourisankar, Basel Karim, et al.Chemistry & Biology|June 25, 2011
In situ kinase profiling reveals functionally relevant properties of native kinasesMatthew P Patricelli, Tyzoon K Nomanbhoy, Jiangyue Wu, et al.Nature|October 3, 2000
A chemical switch for inhibitor-sensitive alleles of any protein kinaseA C Bishop, J A Ubersax, D T Petsch, et al.Oncotarget|September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastomaNathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.Journal of Medicinal Chemistry|January 28, 2025
Development of Potent and Selective CK1α Molecular Glue DegradersQixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.Analytical Chemistry|October 4, 2021
PRM-LIVE with Trapped Ion Mobility Spectrometry and Its Application in Selectivity Profiling of Kinase InhibitorsHe Zhu, Scott B Ficarro, William M Alexander, et al.Journal of Virology|January 29, 2011
Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loopPenny L Moore, Elin S Gray, Daniel Sheward, et al.Molecular Cancer Therapeutics|September 3, 2010
Discovery and characterization of novel mutant FLT3 kinase inhibitorsEllen Weisberg, Hwan Geun Choi, Rosemary Barrett, et al.Pageof 156